Stocks and Investing Stocks and Investing
Wed, March 21, 2012

Matt Miksic Maintained (ABT) at Hold with Increased Target to $60 on, Mar 21st, 2012


Published on 2024-10-24 23:22:32 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Credit Suisse, Maintained "Abbott Laboratories" (ABT) at Hold with Increased Target from $56 to $60 on, Mar 21st, 2012.

Matt has made no other calls on ABT in the last 4 months.



There is 1 other peer that has a rating on ABT. Out of the 1 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matt


  • Brittany Henderson of "Deutsche Bank" Upgraded from Hold to Strong Buy and Increased Target to $70 on, Monday, March 19th, 2012
Contributing Sources